Concepedia

Ann Arfsten

AA

32

Publications

2.9K

Citations

24

H-Index

1978

Active since

Affiliations

Millennium Engineering and Integration (United States)(Current)

Planet Biotechnology (United States)

University of Wisconsin–Madison

Eli Lilly (United States)

Portola Pharmaceuticals (United States)

Ann Arfsten is an author at Millennium Engineering and Integration (United States) specializing in medicine, pharmacology, and natural sciences.

Top concepts

Publications per year

1978–2011

32

Publications

32

Atrial natriuretic peptide clearance receptor. Complete sequence and functional expression of cDNA clones.

Forrest Fuller, J G Porter, Ann Arfsten et al. · Journal of Biological Chemistry · 1988 · 480 citations · Full text

, , +20

Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb-IIIa.

Robert M. Scarborough, M.A. Naughton, Wei-Ning Teng et al. · Journal of Biological Chemistry · 1993 · 371 citations · Full text

Characterization of the integrin specificities of disintegrins isolated from American pit viper venoms.

Robert M. Scarborough, Jack W. Rose, M.A. Naughton et al. · Journal of Biological Chemistry · 1993 · 293 citations · Full text

Effect of Ca <sup>2+</sup> on GP IIb-IIIa Interactions With Integrilin

David R. Phillips, Ann Arfsten, Lisa Nannizzi‐Alaimo et al. · Circulation · 1997 · 248 citations

In vitro expression of Escherichia coli ribosomal protein genes: autogenous inhibition of translation.

J L Yates, Ann Arfsten, M Nomura · Proceedings of the National Academy of Sciences · 1980 · 175 citations · Full text

, , +18

Rows per page

1–5 of 32